PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 12 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $31,019,000 | -31.6% | 22,050,000 | -26.6% | 0.03% | -32.6% |
| Q3 2016 | $45,358,000 | +6.9% | 30,050,000 | +5.3% | 0.05% | -2.1% |
| Q2 2016 | $42,419,000 | -20.3% | 28,550,000 | +18.7% | 0.05% | -29.9% |
| Q1 2016 | $53,231,000 | -38.0% | 24,050,000 | -12.5% | 0.07% | -28.7% |
| Q4 2015 | $85,831,000 | +48.9% | 27,500,000 | -17.2% | 0.09% | +70.9% |
| Q3 2015 | $57,657,000 | -39.0% | 33,214,000 | 0.0% | 0.06% | -32.9% |
| Q2 2015 | $94,476,000 | -11.3% | 33,214,000 | +11.5% | 0.08% | -18.8% |
| Q1 2015 | $106,468,000 | +2.4% | 29,778,000 | +2.6% | 0.10% | -1.0% |
| Q4 2014 | $103,948,000 | -10.3% | 29,028,000 | -2.0% | 0.10% | -15.7% |
| Q3 2014 | $115,835,000 | -1.9% | 29,628,000 | -6.3% | 0.12% | -10.4% |
| Q2 2014 | $118,065,000 | – | 31,628,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |